Simulations Plus (NASDAQ:SLP) Cut to Hold at Zacks Research

Zacks Research cut shares of Simulations Plus (NASDAQ:SLP) from a strong-buy rating to a hold rating in a research report sent to investors on Monday morning,Zacks.com reports.

Several other brokerages also recently weighed in on SLP. Citigroup reiterated a “market perform” rating on shares of Simulations Plus in a research note on Tuesday, January 6th. BTIG Research downgraded Simulations Plus from a “buy” rating to a “neutral” rating in a research note on Thursday, December 18th. TD Cowen reiterated a “hold” rating on shares of Simulations Plus in a research note on Thursday, January 8th. KeyCorp reissued a “sector weight” rating on shares of Simulations Plus in a report on Wednesday, October 29th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Simulations Plus in a report on Wednesday, October 8th. Three investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $25.00.

Simulations Plus Stock Down 3.8%

SLP opened at $14.82 on Monday. Simulations Plus has a 52 week low of $12.39 and a 52 week high of $37.67. The business’s 50 day moving average is $18.94 and its two-hundred day moving average is $16.56. The firm has a market cap of $298.62 million, a price-to-earnings ratio of -4.63 and a beta of 1.12.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Thursday, January 8th. The technology company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.05). The business had revenue of $18.42 million during the quarter, compared to analyst estimates of $18.05 million. Simulations Plus had a negative net margin of 81.66% and a positive return on equity of 14.02%. During the same period in the previous year, the firm earned $0.17 earnings per share. Equities analysts expect that Simulations Plus will post 1.09 EPS for the current fiscal year.

Institutional Trading of Simulations Plus

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Raymond James Financial Inc. acquired a new position in Simulations Plus during the second quarter worth about $25,000. Quarry LP purchased a new stake in shares of Simulations Plus during the 3rd quarter worth approximately $28,000. CWM LLC grew its holdings in shares of Simulations Plus by 3,729.1% in the 3rd quarter. CWM LLC now owns 2,106 shares of the technology company’s stock worth $32,000 after acquiring an additional 2,051 shares during the period. Farther Finance Advisors LLC acquired a new stake in shares of Simulations Plus in the 3rd quarter worth approximately $40,000. Finally, AlphaQuest LLC purchased a new position in Simulations Plus in the 2nd quarter valued at approximately $69,000. Institutional investors and hedge funds own 78.08% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.